Get in Touch
0
0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Research Tools
The Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch Q&A with Omid Farokhzad
We interviewed Omid Farokhzad about the Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch.
April 20, 2022
DeciBio Q&A
Research Tools
The Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch Q&A with Omid Farokhzad
We interviewed Omid Farokhzad about the Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch.
April 20, 2022
Clinical Diagnostics
Proteomics Market
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2022 Update
From ViVE 2022 to exciting regulatory approvals, product launches, partnerships, and acquisitions for the digital health space, Q1 2022 is off to an eventful start.
April 5, 2022
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2022 Update
From ViVE 2022 to exciting regulatory approvals, product launches, partnerships, and acquisitions for the digital health space, Q1 2022 is off to an eventful start.
April 5, 2022
Digital Health
Health Technology Market
Medical Devices
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Liquid Biopsy (LBx) continues to develop with each month, featuring more clinical trial updates and platform launches as well as new LBx approvals worldwide.
April 4, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Liquid Biopsy (LBx) continues to develop with each month, featuring more clinical trial updates and platform launches as well as new LBx approvals worldwide.
April 4, 2022
Liquid Biopsy
DeciBio Q&A
Research Tools
DeciBio’s Single Cell Q&A with Sean Mackay of IsoPlexis
The field of single cell continues to evolve at a remarkable pace. We caught up with CEO and co-founder Sean Mackay to hear more about recent developments at the company.
March 29, 2022
DeciBio Q&A
Research Tools
DeciBio’s Single Cell Q&A with Sean Mackay of IsoPlexis
The field of single cell continues to evolve at a remarkable pace. We caught up with CEO and co-founder Sean Mackay to hear more about recent developments at the company.
March 29, 2022
Spatial Omics
Proteomics Market
DeciBio Q&A
Research Tools
DeciBio's Spatial Omics Q&A with Michael Schnall-Levin of 10x Genomics
Our research tools consulting experts discuss the exciting spatial omics market with Michael Schnall-Levin, specifically how novel technologies are enabling high-plex spatial imaging for translational and discovery research.
March 15, 2022
DeciBio Q&A
Research Tools
DeciBio's Spatial Omics Q&A with Michael Schnall-Levin of 10x Genomics
Our research tools consulting experts discuss the exciting spatial omics market with Michael Schnall-Levin, specifically how novel technologies are enabling high-plex spatial imaging for translational and discovery research.
March 15, 2022
Translational research
Spatial imaging
Spatial Omics
Immuno-Oncology
Spatial transcriptomics
DeciBio Q&A
Research Tools
DeciBio's Spatial Omics Q&A with Niro Ramachandran of Akoya Biosciences
Our research tools consulting experts discuss the exciting spatial omics market with Niro Ramachandran.
March 9, 2022
DeciBio Q&A
Research Tools
DeciBio's Spatial Omics Q&A with Niro Ramachandran of Akoya Biosciences
Our research tools consulting experts discuss the exciting spatial omics market with Niro Ramachandran.
March 9, 2022
Spatial Omics
Spatial imaging
Immuno-Oncology
Translational research
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions